elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26995399-C7506300-AB38-41B5-A05A-EF358739C20E
Q26995399-C7506300-AB38-41B5-A05A-EF358739C20E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26995399-C7506300-AB38-41B5-A05A-EF358739C20E
Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges
P2860
Q26995399-C7506300-AB38-41B5-A05A-EF358739C20E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26995399-C7506300-AB38-41B5-A05A-EF358739C20E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dbee4c305ab87bc52f07bcda2c0ff3acdbce7e55
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer